FDA Approved: PANTOPRAZOLE SODIUM DELAYED-RELEASE DELAYED RELEASE — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approves Cipla USA Inc.'s pantoprazole sodium delayed-release granules as an original generic pantoprazole product (ANDA 217458) for acid-related disorders.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Pantoprazole Sodium Delayed-Release Granules (pantoprazole sodium)

Snippet

ORIG AP for PANTOPRAZOLE SODIUM DELAYED-RELEASE DELAYED RELEASE (PANTOPRAZOLE SODIUM GRANULES)